Insulin-like growth factor–1 and risk of late-onset Alzheimer's disease: findings from a family study
Authors:
- E. van ExelEEE. van Exel
- P. EikelenboomPEP. Eikelenboom
- H. ComijsHCH. Comijs
- D.J.H. DeegDDD.J.H. Deeg
- M.L. StekMSM.L. Stek
- R.G.J. WestendorpRWR.G.J. Westendorp
- 1 March 2014
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 35 (3) , 725.e7-725.e10
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Aging (R03 AG 276163-01)
- EU project LifeSpan (LSHG-CT-2007-036894)
- Internationale Stichting Alzheimer Onderzoek
- Netherlands Ministry of Health Welfare and Sports
- Institute for Health and Care Research
This publication has 10 references indexed in Scilit:
- Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndromeAppetite, 2012
- Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old womenEuropean Journal of Endocrinology, 2011
- Extending Healthy Life Span—From Yeast to HumansScience, 2010
- Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in MiceCell, 2009
- Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levelsNeurology, 2009
- DNA damage and ageing: new-age ideas for an age-old problemNature Cell Biology, 2008
- Insulin/Insulin-Like Growth Factor-1 Signaling and Cognitive Function in HumansThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2008
- Genes encoding longevity: from model organisms to humansAging Cell, 2008
- Insulin-like growth factor I (IGF-I) and cognitive decline in older personsNeurobiology of Aging, 2003
- A Prospective Study on Circulating Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins, and Cognitive Function in the ElderlyThe Journal of Clinical Endocrinology & Metabolism, 2000